Table 1.
Ipsilateral tumor extension within two body compartments |
Neck-chest, chest-abdomen, abdomen-pelvis |
Neck |
Tumor encasing carotid and/or vertebral artery and/or internal jugular vein |
Tumor extending to base of skull |
Tumor compressing the trachea |
Cervico-thoracic junction |
Tumor encasing brachial plexus roots |
Tumor encasing subclavian vessels and/or vertebral and/or carotid artery |
Tumor compressing the trachea |
Thorax |
Tumor encasing the aorta and/or major branches |
Tumor compressing the trachea and/or principal bronchi |
Lower mediastinal tumor, infiltrating the costo-vertebral junction between T9 and T12 |
Thoraco-abdominal |
Tumor encasing the aorta and/or vena cava |
Abdomen/pelvis |
Tumor infiltrating the porta hepatis and/or the hepatoduodenal ligament |
Tumor encasing branches of the superior mesenteric artery at the mesenteric root |
Tumor encasing the origin of the coeliac axis, and/or of the superior mesenteric artery |
Tumor invading one or both renal pedicles |
Tumor encasing the aorta and/or vena cava |
Tumor encasing the iliac vessels |
Pelvic tumor crossing the sciatic notch |
Intraspinal tumor extension whatever the location provided that: |
More than one third of the spinal canal in the axial plane is invaded and/or the perimedullary leptomeningeal spaces are not visible and/or the spinal cord signal is abnormal |
Infiltration of adjacent organs/structures |
Pericardium, diaphragm, kidney, liver, duodeno-pancreatic block, and mesentery |
Conditions to be recorded, but not considered IDRFs |
Multifocal primary tumors |
Pleural effusion, with or without malignant cells |
Ascites, with or without malignant cells |
Abbreviation: IDRFs, image-defined risk factors.